These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 28677499)
1. Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals. Lin X; Ammosova T; Kumari N; Nekhai S Curr Pharm Des; 2017; 23(28):4122-4132. PubMed ID: 28677499 [TBL] [Abstract][Full Text] [Related]
2. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription. Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598 [TBL] [Abstract][Full Text] [Related]
3. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934 [TBL] [Abstract][Full Text] [Related]
4. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9. Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357 [TBL] [Abstract][Full Text] [Related]
5. Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1. Ammosova T; Platonov M; Yedavalli VR; Obukhov Y; Gordeuk VR; Jeang KT; Kovalskyy D; Nekhai S PLoS One; 2012; 7(6):e39481. PubMed ID: 22768081 [TBL] [Abstract][Full Text] [Related]
6. Anti-HIV effect of iron chelators: different mechanisms involved. van Asbeck BS; Georgiou NA; van der Bruggen T; Oudshoorn M; Nottet HS; Marx JJ J Clin Virol; 2001 Feb; 20(3):141-7. PubMed ID: 11166663 [TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinases as therapeutic targets for HIV-1 infection. Rice AP Expert Opin Ther Targets; 2016 Dec; 20(12):1453-1461. PubMed ID: 27797603 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Kumari N; Kulkarni AA; Lin X; McLean C; Ammosova T; Ivanov A; Hipolito M; Nekhai S; Nwulia E Drug Des Devel Ther; 2015; 9():5051-60. PubMed ID: 26366056 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1. Tyagi M; Iordanskiy S; Ammosova T; Kumari N; Smith K; Breuer D; Ilatovskiy AV; Kont YS; Ivanov A; Üren A; Kovalskyy D; Petukhov M; Kashanchi F; Nekhai S Retrovirology; 2015 Jul; 12():63. PubMed ID: 26178009 [TBL] [Abstract][Full Text] [Related]
10. 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. Ammosova T; Platonov M; Ivanov A; Kont YS; Kumari N; Kehn-Hall K; Jerebtsova M; Kulkarni AA; Uren A; Kovalskyy D; Nekhai S Br J Pharmacol; 2014 Nov; 171(22):5059-75. PubMed ID: 25073485 [TBL] [Abstract][Full Text] [Related]
11. Role of cellular iron and oxygen in the regulation of HIV-1 infection. Nekhai S; Kumari N; Dhawan S Future Virol; 2013 Mar; 8(3):301-311. PubMed ID: 23678366 [TBL] [Abstract][Full Text] [Related]
12. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026 [TBL] [Abstract][Full Text] [Related]
13. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. Lacombe B; Morel M; Margottin-Goguet F; Ramirez BC J Virol; 2016 Dec; 90(23):10972-10980. PubMed ID: 27681137 [TBL] [Abstract][Full Text] [Related]
14. Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. Prasad S; Tyagi AK Food Funct; 2015 Nov; 6(11):3412-9. PubMed ID: 26404185 [TBL] [Abstract][Full Text] [Related]
15. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. Zhang HS; Ruan Z; Sang WW J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis. Georgiou NA; van der Bruggen T; Oudshoorn M; Hider RC; Marx JJ; van Asbeck BS Eur J Clin Invest; 2002 Mar; 32 Suppl 1():91-6. PubMed ID: 11886438 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics. de la Fuente C; Maddukuri A; Kehn K; Baylor SY; Deng L; Pumfery A; Kashanchi F Curr HIV Res; 2003 Apr; 1(2):131-52. PubMed ID: 15043199 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. Georgiou NA; van der Bruggen T; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS J Infect Dis; 2000 Feb; 181(2):484-90. PubMed ID: 10669330 [TBL] [Abstract][Full Text] [Related]
19. Stages of HIV replication and targets for therapeutic intervention. Tözsér J Curr Top Med Chem; 2003; 3(13):1447-57. PubMed ID: 14529520 [TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits HIV-1 by promoting Tat protein degradation. Ali A; Banerjea AC Sci Rep; 2016 Jun; 6():27539. PubMed ID: 27283735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]